Title : ATF2 contributes to cisplatin resistance in non-small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway.

Pub. Date : 2015 Jun 1

PMID : 25359574






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 ATF2 contributes to cisplatin resistance in non-small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway. celastrol activating transcription factor 2 Homo sapiens
2 Celastrol-mediated ATF2/cJUN activity was measured. celastrol activating transcription factor 2 Homo sapiens
3 By contrast, Celastrol-mediated ATF2/cJUN functional inhibition restored the response to CDDP. celastrol activating transcription factor 2 Homo sapiens
4 Altogether, our results indicate a potential increase in CDDP sensitivity, on Celastrol-mediated ATF2/cJUN inhibition. celastrol activating transcription factor 2 Homo sapiens